VistaGen Therapeutics (VTGN) Granted Japanese Patent for AV-101 for Treatment of Depression and Hyperalgesia
Tweet Send to a Friend
VistaGen Therapeutics (NASDAQ: VTGN) today announced that the Japan Patent Office (JPO) has issued a patent related to methods of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE